Ie-Ming Shih

Oncology · 2003–2017

A researcher in the Science corpus: 13 papers; trusts 2 researchers and is trusted by 3 researchers here, as inferred from the citation graph.

Subfields

Whom Ie-Ming Shih trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. R. Kurman
  2. V. Beral

Who trusts Ie-Ming Shih overall

  1. R. Kurman
  2. E. Lengyel
  3. J. Prat

Papers from Ie-Ming Shih's perspective

Ordered by how strongly the researchers Ie-Ming Shih trusts endorse each paper. Same corpus, a different order for every researcher.

  1. The Tubal Fimbria Is a Preferred Site for Early Adenocarcinoma in Women With Familial Ovarian Cancer Syndrome (American Journal of Surgical Pathology)
  2. Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer (Journal of Pathology)
  3. Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status (Nature)
  4. PD-1 blockade in tumors with mismatch repair deficiency. (Journal of Clinical Oncology)
  5. Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial. (The Lancet)
  6. Mutation of the PIK3CA Gene in Ovarian and Breast Cancer (Cancer Research)
  7. A candidate precursor to serous carcinoma that originates in the distal fallopian tube
  8. Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma (Science)
  9. Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. (American Journal of Human Genetics)
  10. ARID1A mutations in endometriosis-associated ovarian carcinomas. (New England Journal of Medicine)

Their papers